Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan A Hahn

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Nature Cancer|February 5, 2022
TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancerMengyu Tu, Lukas Klein, Elisa Espinet, et al.
Science Advances|October 13, 2023
Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcriptionDonald P Cameron, Jan Grosser, Swetlana Ladigan, et al.
Elife|November 14, 2023
Human skeletal muscle organoids model fetal myogenesis and sustain uncommitted PAX7 myogenic progenitorsLampros Mavrommatis, Hyun-Woo Jeong, Urs Kindler, et al.
Molecular Cancer Research : MCR|June 6, 2023
Identification of a ΔNp63-Dependent Basal-Like A Subtype-Specific Transcribed Enhancer Program (B-STEP) in Aggressive Pancreatic Ductal AdenocarcinomaXin Wang, Ana P Kutschat, Joana Aggrey-Fynn, et al.
Gut|March 8, 2023
Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancerFeda H Hamdan, Amro M Abdelrahman, Ana Patricia Kutschat, et al.
International Journal of Cancer|August 22, 2012
Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinomaAlexander Baraniskin, Stefanie Nöpel-Dünnebacke, Maike Ahrens, et al.
Gut|September 3, 2020
Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancerJohann Gout, Lukas Perkhofer, Mareen Morawe, et al.
Cancer Research|March 13, 2019
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal CancerJörn Weisner, Ina Landel, Christoph Reintjes, et al.
Cancer & Metabolism|December 10, 2022
Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinomaIrina Heid, Corinna Münch, Sinan Karakaya, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 26, 2014
A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancerRandall E Brand, Alex T Adai, Barbara A Centeno, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Nature Cancer|February 5, 2022
TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancerMengyu Tu, Lukas Klein, Elisa Espinet, et al.
Science Advances|October 13, 2023
Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcriptionDonald P Cameron, Jan Grosser, Swetlana Ladigan, et al.
Elife|November 14, 2023
Human skeletal muscle organoids model fetal myogenesis and sustain uncommitted PAX7 myogenic progenitorsLampros Mavrommatis, Hyun-Woo Jeong, Urs Kindler, et al.
Molecular Cancer Research : MCR|June 6, 2023
Identification of a ΔNp63-Dependent Basal-Like A Subtype-Specific Transcribed Enhancer Program (B-STEP) in Aggressive Pancreatic Ductal AdenocarcinomaXin Wang, Ana P Kutschat, Joana Aggrey-Fynn, et al.
Gut|March 8, 2023
Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancerFeda H Hamdan, Amro M Abdelrahman, Ana Patricia Kutschat, et al.
International Journal of Cancer|August 22, 2012
Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinomaAlexander Baraniskin, Stefanie Nöpel-Dünnebacke, Maike Ahrens, et al.
Gut|September 3, 2020
Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancerJohann Gout, Lukas Perkhofer, Mareen Morawe, et al.
Cancer Research|March 13, 2019
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal CancerJörn Weisner, Ina Landel, Christoph Reintjes, et al.
Cancer & Metabolism|December 10, 2022
Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinomaIrina Heid, Corinna Münch, Sinan Karakaya, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 26, 2014
A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancerRandall E Brand, Alex T Adai, Barbara A Centeno, et al.
Pageof 9